The results revealed that the concentration of cellular ATP was repressed after treatment with the Drp1 inhibitor Mdivi-1 or expression of siDrp1 in EBV-LMP1-positive NPC cells (Fig. 2l, Supplementary Fig. 7g). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.